Stereotactic radiotherapy in the liver hilum: Basis for future studies

Strahlentherapie und Onkologie

Volumn 188, Issue 1, 2012, Pages 35-41

  Zamboglou, C ^a   Memer, M B ^a   Becker, G ^a   Momm, F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cholangiocellular carcinoma; Liver hilum; Pancreatic cancer; Stereotactic body radiotherapy

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER SURVIVAL; COLON; DUODENUM PERFORATION; DUODENUM ULCER; GASTROINTESTINAL HEMORRHAGE; HUMAN; IMAGE GUIDED RADIOTHERAPY; KIDNEY; KLATSKIN TUMOR; LUNG HILUS; MEDICAL LITERATURE; NAUSEA AND VOMITING; PANCREAS CANCER; RADIATION DOSE; SMALL INTESTINE PERFORATION; SPINAL CORD; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; TREATMENT PLANNING; TUMOR VOLUME;

BILE DUCT NEOPLASMS; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; FOLLOW-UP STUDIES; HEPATIC DUCT, COMMON; KLATSKIN'S TUMOR; LIVER; PANCREATIC NEOPLASMS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; SURVIVAL RATE;

EID: 84856356403     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0002-2     Document Type: Article

References (37)

1. Astner ST, Theodoru M, Dobrei-Ciuchendea M et al (2010) Tumor shrinkage assessed by volumetric MRI in the long-term follow-up after stereotactic radiotherapy of meningeomas. Strahlenther Onkol 186:423-429
2. Becker G, Momm F, Schwacha H et al (2005) Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case report. World J Gastroenterol 11:4923-4926 (Pubitemid 41223313)
3. Blomgren H, Lax I, Näslund I, Svanström R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34:861-870
4. Brunner TB, Eccles CL (2010) Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma. Strahlenther Onkol 186:672-680
5. Casamassima F, Cavedon C, Francescon P et al (2006) Use of motion tracking in stereotactic body radiotherapy: evaluation of uncertainty in off-target dose distribution and optimization strategies. Acta Oncol 45:943-947 (Pubitemid 44423143)
6. Case RB, Moseley DJ, Sonke JJ et al (2010) Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. Int J Radiat Oncol Biol Phys 77:918-925
7. Chang DT, Schellenberg D, Shen J et al (2009) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115:665-672
8. Chang BK, Timmerman RD (2007) Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 30:637-644 (Pubitemid 350307190)
9. Chawla S, Chen Y, Katz AW et al (2009) Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 75:71-75
10. Dawson LA, Eccles C, Bissonnette JP, Brock KK (2005) Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 62:1247-1252 (Pubitemid 40884441)
11. Fuss M, Salter BJ, Cavanaugh SX et al (2004) Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 59:1245-1256 (Pubitemid 38834321)
12. Goodman KA, Wiegner EA, Maturen KE et al (2010) Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78:486-493
13. Herfarth KK, Debus J, Lohr F et al (2000) Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 46:329-335 (Pubitemid 30067782)
14. Herfarth KK, Debus J, Lohr F et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19:164-170 (Pubitemid 32063493)
15. Herfarth KK, Debus J, Lohr F et al (2001) Stereotactic irradiation of liver metastases. Radiologe 41:64-68
16. Hoyer M, Roed H, Sengelov L et al (2005) Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 76:48-53 (Pubitemid 41096514)
17. Jensen AD, Grehn C, Nikoghosyan A et al (2009) Catch me if you can - the use of image guidance in the radiotherapy of an unusual case of esophageal cancer. Strahlenther Onkol 185:469-473
18. Köhler FM, Boda-Heggemann J, Küpper B et al (2009) Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple fiducials. Strahlenther Onkol 185:49-55
19. Koong AC, Christofferson E, Le QT et al (2005) Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 63:320-323 (Pubitemid 41317146)
20. Koong AC, Le QT, Ho A et al (2004) Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58:1017-1021 (Pubitemid 38314781)
21. Kopek N, Holt MI, Hansen AT, Høyer M (2010) Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 94:47-52
22. Lax I, Blomgren H, Näslund I, Svanström R (1994) Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33:677-683 (Pubitemid 24345376)
23. Mahadevan A, Jain S, Goldstein M et al (2010) Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 78:735-742
24. Minn AY, Schellenberg D, Maxim P et al (2009) Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment. Am J Clin Oncol 32:364-368
25. Momm F, Schubert E, Henne K et al (2010) Stereotactic fractionated radiotherapy for Klatskin tumours. Radiother Oncol 95:99-102
26. Murphy JD, Christman-Skieller C, Kim J et al (2010) Adosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 78:1420-1426
27. Oshiro Y, Aruga T, Tsuboi K et al (2010) Stereotactic body radiotherapy for lung tumors at the pulmonary hilum. Strahlenther Onkol 186:274-279
28. Polistina F, Constantin G, Casamassima F et al (2010) Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Ann Surg Oncol 17:2092-2101.
29. Rwigema JC, Parikh SD, Heron DE et al (2011) Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 34:63-69
30. Schellenberg D, Quon A, Minn AY et al (2010) 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 77:1420-1425
31. Seo YS, Kim MS, Yoo S et al (2009) Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 75:1456-1461
32. Timmerman RD, Kavanagh BD, Cho LC et al (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25:947-952 (Pubitemid 350002860)
33. Timmerman R, Papiez L, Suntharalingam M (2003) Extracranial stereotactic radiation delivery: expansion of technology beyond the brain. Technol Cancer Res Treat 2:153-160 (Pubitemid 36569483)
34. Tse RV, Hawkins M, Lockwood G et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657-664 (Pubitemid 351264363)
35. Voigtmann K, Köllner V, Einsle F et al (2010) Emotional state of patients in radiotherapy and how they deal with their disorder. Strahlenther Onkol 186:229-235
36. Wulf J, Hädinger U, Oppitz U et al (2001) Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177:645-655 (Pubitemid 34015341)
37. Wulf J, Hädinger U, Oppitz U et al (2000) Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 57:225-236